📄 Abstract
Adverse Drug Reactions (ADRs) are a major concern in clinical practice and significantly contribute to morbidity and mortality worldwide [1]. Pharmacovigilance plays a crucial role in detecting, assessing, and preventing ADRs [2]. In India, the Pharmacovigilance Programme of India (PvPI) has been established to monitor drug safety [3]. However, underreporting remains a major challenge due to lack of awareness and inadequate training [4].
📚 How to Cite:
Abhishek Sharma , Deepali Sharma , Ayush Gupta , ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES , Volume 11 , Issue 3, March 2026, EPRA International Journal of Research & Development (IJRD) , DOI: https://doi.org/10.36713/epra26594